Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
In vivo bradykinin B2 receptor activation reduces renal fibrosis
Joost P. Schanstra, Eric Neau, Pascale Drogoz, Miguel A. Arevalo Gomez, José Miguel Lopez Novoa, Denis Calise, Christiane Pecher, Michael Bader, Jean-Pierre Girolami, Jean-Loup Bascands
Joost P. Schanstra, Eric Neau, Pascale Drogoz, Miguel A. Arevalo Gomez, José Miguel Lopez Novoa, Denis Calise, Christiane Pecher, Michael Bader, Jean-Pierre Girolami, Jean-Loup Bascands
View: Text | PDF
Article Genetics

In vivo bradykinin B2 receptor activation reduces renal fibrosis

  • Text
  • PDF
Abstract

Research Article

Authors

Joost P. Schanstra, Eric Neau, Pascale Drogoz, Miguel A. Arevalo Gomez, José Miguel Lopez Novoa, Denis Calise, Christiane Pecher, Michael Bader, Jean-Pierre Girolami, Jean-Loup Bascands

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Quantitative analysis of UUO-induced renal interstitial collagen express...
Quantitative analysis of UUO-induced renal interstitial collagen expression in B2–/– knockout mice, kallikrein transgenic rats, and B2 receptor antagonist–treated wild-type mice. (a) Collagen expression in obstructed kidneys from B2+/+ and B2–/– mice after different periods of ureteral obstruction (3 hours to 14 days). Data are expressed as the mean ± SD percentage of the interstitial area stained; n = 10; *P < 0.05 compared with respective B2+/+ (same time of obstruction). (b) Representative photographs of Sirius red–stained renal sections of 5 day–obstructed and sham-operated B2+/+ and B2–/– mice. Original magnification ×400. (c) Collagen expression in kidneys from 5 day–obstructed and sham-operated kallikrein transgenic and control (Sprague Dawley) rats. One group was treated with HOE-140. n = 5 per group. *P < 0.05 compared with sham-operated rats; ‡P < 0.05 compared with UUO kallikrein transgenic rats without HOE-140. (d) Collagen expression in kidneys from 5 day–obstructed B2+/+ mice treated with saline only or with saline containing HOE-140 at 500 μg/kg/d; n = 10 per group. Data expressed as the mean ± SD percentage of the interstitial area stained; *P < 0.05 compared to without HOE-140.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts